PharmDr. Adéla Bártová
Researcher, Scientific Director's Section
correspondence Address:
Palachovo nám. 726/3, 625 00 Brno
office: bldg. A16/123
Kamenice 753/5
625 00 Brno
phone: | +420 549 49 3186 |
---|---|
e‑mail: | adela.bartova@med.muni.cz |
social and academic networks: |
---|
Total number of publications: 9
2024
-
Addressing Legislative and Financial Hurdles in Rare Disease Medicines Accessibility: Insight From Czechia With a Focus on the Pediatric Population
Year: 2024, type: Conference abstract
-
Exploring Real-World Data Based Financing Models For Lung Cancer Immunotherapy In The Czech Republic
Year: 2024, type: Conference abstract
-
Legislativní a etický problém dostupnosti orphan drugs a ATMPs (Advanced Therapy Medicinal Products)
Year: 2024, type: Appeared in Conference without Proceedings
-
Návrh dohody o sdílení rizik na základě reálných klinických dat: Případová studie imunoterapie v léčbě renálního karcinomu
Year: 2024, type: Article in Periodical (without peer review)
-
Performance-based risk-sharing agreements v onkologii v českých podmínkách: Outcomes, výhody, nevýhody a překážky, dostupnost dat v Česku, teoretický model a návrh možného agreement
Year: 2024, type: Appeared in Conference without Proceedings
2023
-
Implementation of risk-sharing agreement in patients with lung cancer treated with immunotherapy based on RWD in the Czech Republic
Year: 2023, type: Conference abstract
-
Imunoterapie u pacientů s karcinomem plic na MOÚ: účinnost, bezpečnost a náklady
Year: 2023, type: Conference abstract
2022
-
Immune-Mediated Adverse Effects of Checkpoint Inhibitors: A Clinical Experience
European Pharmaceutical Journal, year: 2022, volume: 69, edition: s1, DOI
-
Molecular tumor boards a personalizovaná medicína v českých onkologických centrech
Year: 2022, type: Conference abstract